-
2022-501026-37-00
4
ACLF is a syndrome that occurs in patients with chronic liver disease,
-
2022-501535-16-00
5
Atopic Dermatitis (AD)
-
2022-502779-40-99
5
Primary prevention of atherosclerotic cardiovascular disease (ASCVD)
-
2023-509176-42-00
11
Obesity and T2D
-
2024-513676-18-00
5
Transthyretin Amyloidosis
-
2024-515605-26-00
2
No medical condition.
-
2024-517732-21-00
2
No medical condition.
-
2024-518013-25-00
4
Idiopathic Pulmonary Fibrosis
-
2024-520218-23-00
10
Pulmonary Arterial Hypertension
-
2025-520554-11-00
5
Cardiovascular Disease
-
2025-520565-51-00
5
small cell lung cancer
-
2025-521632-12-00
5
Patients on Factor Xa inhibitor treatment needing an urgent interventi
-
2025-521709-42-00
5
Allergic rhinoconjunctivitis with or without asthma due to clinically
-
2025-521736-10-00
5
Allergic rhinoconjunctivitis with or without controlled asthma
-
2025-521779-30-00
4
Geographic atrophy secondary to age-related macular degeneration
-
2025-523869-22-00
5
advanced or metastatic extrapulmonary neuroendocrine carcinoma
-
2025-524316-11-00
5
Primary Progressive Multiple Sclerosis (PPMS)
-
2024-520446-31-00
5
2026-05-27
Participants with overweight or obesity, and type 2 diabetes
-
2025-524498-17-00
10
2026-05-08
Pretreated Unresectable Locally Advanced or Metastatic human epidermal
-
2024-519830-22-00
5
2026-04-27
Heart failure due to systemic left ventricular systolic dysfunction
-
2024-517943-29-00
5
2026-04-21
Pulmonary Hypertension associated with interstitial lung disease (WHO
-
2025-522191-86-00
5
2026-04-02
Focal segmental glomerulosclerosis
-
2025-521314-25-00
5
2026-03-19
NPM1-m and KMT2A-r Acute Myeloid Leukemia
-
2024-519444-33-00
5
2026-03-12
HER2-expressing endometrial cancer (IHC 3+/2+)